Multisystemic Eosinophilic Epitheliotropic Disease in a Horse in Brazil

    January 2017 in “ Ciência Rural
    Cláudio João Mourão Laisse, Lismara Castro do Nascimento, Welden Panziera, Elizabeth Caldas Soares, Denise Bicca Fernandes, Júlio César Westphalen, Luciana Sonne, Saulo Petinatti Pavarini, David Driemeier
    Image of study
    TLDR A horse in Brazil with skin and gut issues was diagnosed with a severe disease and had to be euthanized.
    A 5-year-old horse in Brazil was diagnosed with equine multisystemic eosinophilic epitheliotropic disease (MEED), presenting symptoms such as pruritus, alopecia, and moderate eosinophilia. Despite treatment with corticosteroids and antibiotics, the condition worsened, leading to fever, diarrhea, gastric reflux, and weight loss, ultimately resulting in euthanasia. Necropsy and histopathological evaluation revealed eosinophilic granulomas in multiple organs, including the skin, oral mucosa, duodenum, pancreas, and mesenteric lymph nodes. The findings suggested that MEED should be considered in horses with skin lesions and gastrointestinal symptoms.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 6 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  451 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

    Similar Research

    5 / 1000+ results